Growing valve PolyVascular is developing a polymer-based pulmonary valve-expandable design aimed at pediatric patients, presenting a recurring sales opportunity with each child’s growth phase and potential long-term valve care partnerships.

Non-surgical edge The company offers the only non-surgical pulmonary valve delivery system suitable for children as young as 2, enabling hospitals to market a less invasive option to families and potentially expand adoption in pediatric cardiology programs.

Clinical validation Recent recognition as overall winner in major health tech competitions and NIH SBIR Phase IIb funding signal strong clinical merit and potential for accelerated adoption—prospects to engage with grant programs, hospital procurement, and research collaborations.

Growth funding With measurable revenue and a reported NIH grant trajectory, there are opportunities to pursue strategic partnerships, co-development deals, and scale manufacturing and supply agreements to support broader clinical trials and commercialization.

Global reach Adoption potential spans pediatric cardiology centers and international markets using ISO, cloud, and e-commerce tooling; sales motions can target hospital systems, distributors, and specialized medical device procurement channels seeking innovative, durable pediatric valves.